Remifentanil-sevoflurane interaction models of circulatory response to laryngoscopy and circulatory depression

British Journal of Anaesthesia

Volumn 110, Issue 5, 2013, Pages 729-740

  Bi, S S ^a,b   Deng, C H ^a,b   Zhou, T Y ^a,b   Guan, Z ^c   Li, L ^a,b   Li, H Q ^a   Zhang, L P ^d   Yang, L ^d   Lu, W ^a,b  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

^d PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

anaesthetics volatile; analgesics opioid; mathematical; model; pharmacodynamic; remifentanil; sevoflurane

Indexed keywords

REMIFENTANIL; SEVOFLURANE;

ADULT; ARTICLE; ASSISTED VENTILATION; CHINESE; CIRCULATION; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG POTENTIATION; DRUG RESPONSE; ELECTIVE SURGERY; FEMALE; HUMAN; LARYNGOSCOPY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MUSCLE RIGIDITY; OPEN STUDY; PARALLEL DESIGN; PHARMACODYNAMICS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESPONSE SURFACE METHOD; SURGICAL PATIENT;

EID: 84876525652     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aes504     Document Type: Article

References (32)

1. Lang E, Kapila A, Shlugman D, Hoke JF, Sebel PS, Glass PS. Reduction of isoflurane minimal alveolar concentration by remifentanil. Anesthesiology 1996; 85: 721-8
2. Li RC, Schentag JJ, Nix DE. The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactions. Antimicrob Agents Chemother 1993; 37: 523-31
3. Gennings C, Carter WH Jr, Carney EW, Charles GD, Gollapudi BB, Carchman RA. A novel flexible approach for evaluating fixed ratio mixtures of full and partial agonists. Toxicol Sci 2004; 80: 134-50
4. Charles GD, Gennings C, Zacharewski TR, Gollapudi BB, Carney EW. An approach for assessing estrogen receptor-mediated interactions in mixtures of three chemicals: a pilot study. Toxicol Sci 2002; 68: 349-60
5. White DB, Slocum HK, Brun Y, Wrzosek C, Greco WR. A new nonlinear mixture response surface paradigm for the study of synergism: a three drug example. Curr Drug Metab 2003; 4: 399-409
6. Germani M, Magni P, De Nicolao G, et al. In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time. Cancer Chemother Pharmacol 2003; 52: 507-13
7. Minto CF, Schnider TW, Short TG, Gregg KM, Gentilini A, Shafer SL. Response surface model for anesthetic drug interactions. Anesthesiology 2000; 92: 1603-16
8. Greco WR, Bravo G, Parsons JC. The search for synergy: a critical review from a response surface perspective. Pharmacol Rev 1995; 47: 331-85
9. Manyam SC, Gupta DK, Johnson KB, et al. Opioid-volatile anesthetic synergy: a response surface model with remifentanil and sevoflurane as prototypes. Anesthesiology 2006; 105: 267-78
10. Short TG, Plummer JL, Chui PT. Hypnotic and anaesthetic interactions between midazolam, propofol and alfentanil. Br J Anaesth 1992; 69: 162-7
11. Short TG, Ho TY, Minto CF, Schnider TW, Shafer SL. Efficient trial design for eliciting a pharmacokinetic-pharmacodynamic modelbased response surface describing the interaction between two intravenous anesthetic drugs. Anesthesiology 2002; 96: 400-8
12. Kern SE, Xie G, White JL, Egan TD. A response surface analysis of propofol-remifentanil pharmacodynamic interaction in volunteers. Anesthesiology 2004; 100: 1373-81
13. Johnson KB, Syroid ND, Gupta DK, et al. An evaluation of remifentanil propofol response surfaces for loss of responsiveness, loss of response to surrogates of painful stimuli and laryngoscopy in patients undergoing elective surgery. Anesth Analg 2008; 106: 471-9
14. Westmoreland CL, Sebel PS, Gropper A. Fentanyl or alfentanil decreases the minimum alveolar anesthetic concentration of isoflurane in surgical patients. Anesth Analg 1994; 78: 23-8
15. Mertens MJ, Olofsen E, Engbers FH, Burm AG, Bovill JG, Vuyk J. Propofol reduces perioperative remifentanil requirements in a synergistic manner: response surface modeling of perioperative remifentanil-propofol interactions. Anesthesiology 2003; 99: 347-59
16. Nieuwenhuijs DJ, Olofsen E, Dahan A, et al. Response surface modeling of remifentanil-propofol interaction on cardiorespiratory control and bispectral index. Anesthesiology 2003; 98: 312-22
17. Johnson KB, Syroid ND, Gupta DK, et al. An evaluation of remifentanil- sevoflurane response surface models in patients emerging from anesthesia: model improvement using effect-site sevoflurane concentrations. Anesth Analg 2010; 111: 387-94
18. Diz JC, Del Río R, Lamas A, Mendoza M, Durán M, Ferreira LM. Analysis of pharmacodynamic interaction of sevoflurane and propofol on Bispectral Index during general anaesthesia using a response surface model. Br J Anaesth 2010; 104: 733-9
19. Dahan A, Nieuwenhuijs D, Olofsen E, Sarton E, Romberg R, Teppema L. Response surface modeling of alfentanil-sevoflurane interaction on cardiorespiratory control and bispectral index. Anesthesiology 2001; 94: 982-91
20. Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 1997; 86: 10-23
21. Cormack RS, Lehane J. Difficult tracheal intubation in obstetrics. Anaesthesia 1984; 39: 1105-11
22. Muzi M, Colinco MD, Robinson BJ, Ebert TJ. The effects of premedication on inhaled induction of anesthesia with sevoflurane. Anesth Analg 1997; 85: 1143-8
23. Berenbaum MC. What is synergy? Pharmacol Rev 1989; 41: 93-141.
24. Hall AP, Thompson JP, Leslie NA, Fox AJ, Kumar N, Rowbotham DJ. Comparison of different doses of remifentanil on the cardiovascular response to laryngoscopy and tracheal intubation. Br J Anaesth 2000; 84: 100-2
25. Maguire AM, Kumar N, Parker JL, Rowbotham DJ, Thompson JP. Comparison of effects of remifentanil and alfentanil on cardiovascular response to tracheal intubation in hypertensive patients. Br J Anaesth 2001; 86: 90-3
26. Mollhoff T, Herregods L, Moerman A, et al. Comparative efficacy and safety of remifentanil and fentanyl in 'fast track' coronary artery bypass graft surgery: a randomized, double-blind study. Br J Anaesth 2001; 87: 718-26
27. De Blasi RA, Palmisani S, Boezi M, et al. Effects of remifentanilbased general anaesthesia with propofol or sevoflurane on muscle microcirculation as assessed by near-infrared spectroscopy. Br J Anaesth 2008; 101: 171-7
28. Katoh T, Kobayashi S, Suzuki A, Iwamoto T, Bito H, Ikeda K. The effect of fentanyl on sevoflurane requirements for somatic and sympathetic responses to surgical incision. Anesthesiology 1999; 90: 398-405
29. Kazama T, Ikeda K, Morita K. Reduction by fentanyl of the Cp50 values of propofol and hemodynamic responses to various noxious stimuli. Anesthesiology 1997; 87: 213-27
30. Smith C, McEwan AI, Jhaveri R, et al. The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision. Anesthesiology 1994; 81: 820-8; discussion 26A
31. Hall RI, Szlam F, Hug CC Jr. The enflurane-sparing effect of alfentanil in dogs. Anesth Analg 1987; 66: 1287-91
32. Heyse B, Proost JH, Schumacher PM, et al. Sevoflurane remifentanil interaction: comparison of different response surface models. Anesthesiology 2012; 116: 311-23